[Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
Neurologischen Universitätspoliklinik Kantonsspital Basel.
L
L
Kappos
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007158:Immunologic Techniques; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012307:Risk Factors
D003524:Cyclosporins; D001379:Azathioprine
Immunsuppressive Therapie der multiplen Sklerose mit Cyclosporin A und Azathioprin. Langzeiteffekte, Risiken, kernspintomographische und immunologische Befunde.